Dr. Andrea Camerini is a medical oncologist, chief of the Lung Cancer Unit and Medical Oncology Day Hospital within the Oncology Department of Azienda USL Toscana Nord-Ovest, Versilia Hospital (Lido di Camaiore, Italy), and oncologist coordinator of the Cardio-Oncology institutional program. After a degree in medicine cum laude in 2000 at the Catholic University of Rome, he trained for and received a specialty in oncology cum laude in 2004 and a PhD in “Integrated Oncology” in 2009 at the Catholic University Medical School in Rome. Dr. Camerini has been an investigator in more than 100 phase II-III-IV GCP clinical trials, mainly regarding lung cancer, with special emphasis on the metronomic approach in the treatment of lung cancer. Additionally, he actively participates in translational research on molecular biology applied to the identification of new prognostic and predictive markers. His steady scientific output includes Medline full papers and posters at major oncology meetings, and he has been an invited speaker at more than 100 international and national oncology meetings. Dr. Camerini is a member of the European Society of Medical Oncology (ESMO), the Italian Association of Medical Oncology (AIOM), the Italian Association of Thoracic Oncology (AIOT) and the Italian Oncology Group for Clinical Research (GOIRC).